Biogen Inc.BIIB

Where BIIB's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$249.65+5.60 (+2.29%)Previous close
NASDAQHealthcare

BIIB Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
BIIB Net Debt / EBITDA historyBIIB Net Debt / EBITDA from Dec 2023 to Sep 2026: low 0.78, high 5.38, latest 5.38.0.411.753.084.415.75Dec 23Jun 24Dec 24Sep 25Mar 26Sep 26med 1.38

BIIB Net Debt / EBITDA by year

Yearly range of BIIB’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.3 to 5.4, averaging 1.3.

BIIB Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.23.45.45.4
20250.81.11.41.4
20241.31.82.31.3
20231.11.82.62.6
20220.81.31.90.9
20211.51.92.51.6
20200.50.81.31.3
20190.40.50.60.4
20180.30.50.70.7
20170.70.80.90.7
20160.70.70.70.7

Get notified when BIIB Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.